DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
SIMPINICLINE
2
Small molecule
Investigational
Unknown
Unknown
Gastroparesis; Dry Eye Syndromes; Irritable Bowel Syndrome
Neuronal acetylcholine receptor; alpha3/beta4 agonist
SIMPINICLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
09936A4QSN
Molecule Type:
Small molecule
Molecular Formula:
C10H13N3
Molecular Weight:
175.23
AlogP:
1.1
PSA:
37.81
HBD:
1.0
HBA:
#RotB:
2.0
Source:
L19SIP 131I
2
Antibody
Investigational
Unknown
Unknown
Neoplasms
Fibronectin other
L19SIP 131I
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DERAZANTINIB
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Cholangiocarcinoma
Fibroblast growth factor receptor inhibitor
DERAZANTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
N9B0H171MJ
Molecule Type:
Small molecule
Molecular Formula:
C29H29FN4O
Molecular Weight:
468.58
AlogP:
5.49
PSA:
59.07
HBD:
2.0
HBA:
#RotB:
9.0
Source:
K201
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
K201
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAK-653
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder
Glutamate receptor ionotropic AMPA positive allosteric modulator
TAK-653
×
Maximum Phase:
2
First Approval:
None
UNII:
9E3TOE5RIZ
Molecule Type:
Small molecule
Molecular Formula:
C19H23N3O3S
Molecular Weight:
373.48
AlogP:
3.11
PSA:
71.33
HBD:
0.0
HBA:
#RotB:
3.0
Source:
ANATUMOMAB MAFENATOX
2
Antibody
Investigational
Unknown
Unknown
Unknown
Trophoblast glycoprotein other
ANATUMOMAB MAFENATOX
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AL-901
2
Antibody
Investigational
Unknown
Unknown
Unknown
Ig epsilon chain C region inhibitor
AL-901
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECALCET HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Calcium sensing receptor modulator
TECALCET HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
3HP28R98LC
Molecule Type:
Small molecule
Molecular Formula:
C18H23Cl2NO
Molecular Weight:
340.29
AlogP:
4.63
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
7.0
Source:
ISLATRAVIR
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ISLATRAVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
QPQ082R25D
Molecule Type:
Small molecule
Molecular Formula:
C12H12FN5O3
Molecular Weight:
293.26
AlogP:
-0.81
PSA:
119.31
HBD:
3.0
HBA:
#RotB:
2.0
Source:
CX 4945
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CX 4945
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CANNABIDIVARIN
2
Small molecule
Investigational
Unknown
Unknown
Epilepsy; Child Development Disorders, Pervasive; Prader-Willi Syndrome
Unknown
CANNABIDIVARIN
×
Maximum Phase:
2
First Approval:
None
UNII:
I198VBV98I
Molecule Type:
Small molecule
Molecular Formula:
C19H26O2
Molecular Weight:
286.42
AlogP:
5.07
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
4.0
Source:
GSK2881078
2
Small molecule
Investigational
Unknown
Unknown
Cachexia
Androgen Receptor modulator
GSK2881078
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIUM PHOSPHATE, TRIBASIC
2
Small molecule
Investigational
Unknown
Unknown
Dental Caries
Unknown
CALCIUM PHOSPHATE, TRIBASIC
×
Maximum Phase:
2
First Approval:
None
UNII:
K4C08XP666
Molecule Type:
Small molecule
Molecular Formula:
Ca3O8P2
Molecular Weight:
310.17
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TAURINE
2
Small molecule
Investigational
Unknown
Unknown
Homocystinuria; Multiple Sclerosis; Bipolar Disorder; Diabetes Mellitus, Type 2; Mental Disorders; Hypertension
Unknown
TAURINE
×
Maximum Phase:
2
First Approval:
None
UNII:
1EQV5MLY3D
Molecule Type:
Small molecule
Molecular Formula:
C2H7NO3S
Molecular Weight:
125.15
AlogP:
-1.17
PSA:
80.39
HBD:
2.0
HBA:
#RotB:
2.0
Source:
LIBIVIRUMAB
2
Antibody
Investigational
Unknown
Unknown
Hepatitis B, Chronic
Unknown
LIBIVIRUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
J1R33H8X7A
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLOVAMER ACETATE
2
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis, Relapsing-Remitting
HLA class II histocompatibility antigen, DRB1-15 beta chain modulator
PLOVAMER ACETATE
×
Maximum Phase:
2
First Approval:
None
UNII:
5511VZ6NRQ
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FUCOXANTHIN
2
Small molecule
Investigational
Unknown
Unknown
Metabolic Syndrome
Unknown
FUCOXANTHIN
×
Maximum Phase:
2
First Approval:
None
UNII:
06O0TC0VSM
Molecule Type:
Small molecule
Molecular Formula:
C40H56O6
Molecular Weight:
632.88
AlogP:
8.14
PSA:
96.36
HBD:
2.0
HBA:
#RotB:
10.0
Source:
AUTOGENE CEVUMERAN
2
Oligonucleotide
Investigational
Unknown
Unknown
Breast Neoplasms; Head and Neck Neoplasms; Kidney Neoplasms; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma
Unknown
AUTOGENE CEVUMERAN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TROXACITABINE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia
DNA polymerase (alpha/delta/epsilon) inhibitor
TROXACITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
60KQZ0388Y
Molecule Type:
Small molecule
Molecular Formula:
C8H11N3O4
Molecular Weight:
213.19
AlogP:
-1.31
PSA:
99.6
HBD:
2.0
HBA:
#RotB:
2.0
Source:
VX-702
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
MAP kinase p38 alpha inhibitor
VX-702
×
Maximum Phase:
2
First Approval:
None
UNII:
527E7SK68P
Molecule Type:
Small molecule
Molecular Formula:
C19H12F4N4O2
Molecular Weight:
404.32
AlogP:
3.62
PSA:
102.31
HBD:
2.0
HBA:
#RotB:
4.0
Source:
MSDC-0160
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MSDC-0160
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HORSE CHESTNUT SEED EXTRACT
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HORSE CHESTNUT SEED EXTRACT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VADACABTAGENE LERALEUCEL
2
Gene
Investigational
Unknown
Unknown
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
VADACABTAGENE LERALEUCEL
×
Maximum Phase:
2
First Approval:
None
UNII:
A4O2H9W17Y
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETARACIZUMAB
2
Antibody
Investigational
Unknown
Unknown
Carcinoma, Renal Cell; Colorectal Neoplasms; Neoplasms; Arthritis, Rheumatoid; Melanoma; Prostatic Neoplasms, Castration-Resistant; Psoriasis
Integrin alpha-V/beta-3 antagonist
ETARACIZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
41W9MFI160
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
T-817
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
T-817
×
Maximum Phase:
2
First Approval:
None
UNII:
QY49O94S2W
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO2S
Molecular Weight:
291.42
AlogP:
2.53
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
7.0
Source:
AMELUBANT
2
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis; Arthritis, Rheumatoid; Asthma; Pulmonary Disease, Chronic Obstructive
Leukotriene B4 receptor 1 antagonist
AMELUBANT
×
Maximum Phase:
2
First Approval:
None
UNII:
E0018IF0K4
Molecule Type:
Small molecule
Molecular Formula:
C33H34N2O5
Molecular Weight:
538.64
AlogP:
6.95
PSA:
100.87
HBD:
3.0
HBA:
#RotB:
10.0
Source:
GRC-17536
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Neuropathies
Transient receptor potential cation channel subfamily A member 1 antagonist
GRC-17536
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HIGH FRUCTOSE CORN SYRUP
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
HIGH FRUCTOSE CORN SYRUP
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ENIBARCIMAB
2
Antibody
Investigational
Unknown
Unknown
Heart Failure; Shock, Septic
ADM stabiliser
ENIBARCIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
JNJ-37822681
2
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Dopamine D2 receptor antagonist
JNJ-37822681
×
Maximum Phase:
2
First Approval:
None
UNII:
GJB2URS7NJ
Molecule Type:
Small molecule
Molecular Formula:
C17H17F5N4
Molecular Weight:
372.34
AlogP:
3.85
PSA:
41.05
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NEVANIMIBE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Cushing Syndrome
Unknown
NEVANIMIBE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
TK694ZFS57
Molecule Type:
Small molecule
Molecular Formula:
C27H40ClN3O
Molecular Weight:
458.09
AlogP:
6.63
PSA:
44.37
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PELITREXOL
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Colorectal Neoplasms; Lung Neoplasms
Unknown
PELITREXOL
×
Maximum Phase:
2
First Approval:
None
UNII:
DHT6E8M4KP
Molecule Type:
Small molecule
Molecular Formula:
C20H25N5O6S
Molecular Weight:
463.52
AlogP:
0.99
PSA:
187.5
HBD:
6.0
HBA:
#RotB:
9.0
Source:
BMS-986142
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis; Arthritis, Rheumatoid
Tyrosine-protein kinase BTK inhibitor
BMS-986142
×
Maximum Phase:
2
First Approval:
None
UNII:
PJX9GH268R
Molecule Type:
Small molecule
Molecular Formula:
C32H30F2N4O4
Molecular Weight:
572.61
AlogP:
4.4
PSA:
123.11
HBD:
3.0
HBA:
#RotB:
4.0
Source:
AMG-208
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms, Castration-Resistant
Hepatocyte growth factor receptor inhibitor
AMG-208
×
Maximum Phase:
2
First Approval:
None
UNII:
Y2SR66P7VM
Molecule Type:
Small molecule
Molecular Formula:
C22H17N5O2
Molecular Weight:
383.41
AlogP:
3.93
PSA:
74.43
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ITACITINIB ADIPATE
2
Small molecule
Investigational
Unknown
Unknown
Bronchiolitis Obliterans
Unknown
ITACITINIB ADIPATE
×
Maximum Phase:
2
First Approval:
None
UNII:
XZG407XE0Y
Molecule Type:
Small molecule
Molecular Formula:
C32H33F4N9O5
Molecular Weight:
699.67
AlogP:
3.6
PSA:
119.62
HBD:
1.0
HBA:
#RotB:
5.0
Source:
1
2
…
190
191
192
193
194
195
196
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA